L Farina

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. doi request reprint The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
    L Farina
    Hematology Department, IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
    Leukemia 23:1131-8. 2009
  2. pmc Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation
    Lucia Farina
    Division of Hematology Bone Marrow Transplantation, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy
    Haematologica 94:654-62. 2009
  3. ncbi request reprint Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
    P Corradini
    Division of Hematology and Bone Marrow Transplantation, Department of Hematology, Istituto Nazionale per lo Studio e la Cura dei Tumori, University of Milano, Milan, Italy
    Leukemia 21:2316-23. 2007
  4. ncbi request reprint Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation
    C Voena
    Laboratorio Ematologia Molecolare, Istituto Scientifico HS Raffaele, Milano, Italy
    Bone Marrow Transplant 32:791-3. 2003
  5. ncbi request reprint Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies
    P Corradini
    Divisione of Ematologia and Ufficio Operativo, Istituto Nazionale Tumori, Universita di Milano, Milano, Italy
    J Clin Oncol 23:6690-8. 2005
  6. pmc Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease
    S Saredi
    Division of Neuromuscular Diseases and Neuroimmunology, Foundation Neurological Institute C Besta, Milano, Italy
    J Neurol Sci 318:45-50. 2012

Collaborators

Detail Information

Publications6

  1. doi request reprint The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
    L Farina
    Hematology Department, IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
    Leukemia 23:1131-8. 2009
    ..Conditioning type did not affect outcome after stratifying patients by HCT-CI. In the light of our study, all future prospective trials of the Gruppo Italiano Trapianti di Midollo (GITMO) will include the HCT-CI to stratify patients...
  2. pmc Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation
    Lucia Farina
    Division of Hematology Bone Marrow Transplantation, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy
    Haematologica 94:654-62. 2009
    ....
  3. ncbi request reprint Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
    P Corradini
    Division of Hematology and Bone Marrow Transplantation, Department of Hematology, Istituto Nazionale per lo Studio e la Cura dei Tumori, University of Milano, Milan, Italy
    Leukemia 21:2316-23. 2007
    ..6), diagnosis of HD (HR=3.5), and acute GVHD (HR=5.9). RIC allogeneic SCT is a feasible and effective salvage strategy in both indolent and aggressive NHL...
  4. ncbi request reprint Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation
    C Voena
    Laboratorio Ematologia Molecolare, Istituto Scientifico HS Raffaele, Milano, Italy
    Bone Marrow Transplant 32:791-3. 2003
    ..These data suggest that real-time molecular follow-up can be used to monitor the GVM effect and that it can be employed in the clinical setting to tailor post transplant immunomodulation...
  5. ncbi request reprint Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies
    P Corradini
    Divisione of Ematologia and Ufficio Operativo, Istituto Nazionale Tumori, Universita di Milano, Milano, Italy
    J Clin Oncol 23:6690-8. 2005
    ....
  6. pmc Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease
    S Saredi
    Division of Neuromuscular Diseases and Neuroimmunology, Foundation Neurological Institute C Besta, Milano, Italy
    J Neurol Sci 318:45-50. 2012
    ..Cerebral MRI is important for identifying MEB and α-dystroglycanopathy phenotypes in children and foetuses, and hence for directing the genetic analysis...